Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
International Journal of Technology Assessment in Health Care
|
September 10, 2003
Who's better not best: appropriate probabilistic uncertainty analysis
Douglas Coyle
Health Economics
|
February 4, 2003
Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues
Douglas Coyle
Journal of Cutaneous Medicine and Surgery
|
July 1, 2005
Cost effectiveness of Elidel in the management of patients with atopic dermatitis in Canada
Douglas Coyle, Martin Barbeau
The Journal of Rheumatology. Supplement
|
January 10, 2004
Towards a reference case for economic evaluation of osteoporosis treatments
Douglas Coyle, Anna N Tosteson
The Canadian Journal of Cardiology
|
February 18, 2004
Economic evaluation of the use of irbesartan and amlodipine in the treatment of diabetic nephropathy in patients with hypertension in Canada
Douglas Coyle, Roger A Rodby
Expert Opinion on Pharmacotherapy
|
April 6, 2002
Pharmacoeconomics of long-term treatment of rheumatoid arthritis
Barbara Blumenauer, Douglas Coyle, Peter Tugwell
Pharmacoeconomics
|
June 17, 2003
Economic evaluation of norethisterone acetate/ethinylestradiol (FemHRT) for women with menopausal symptoms
Douglas Coyle, Ann Cranney, Peter Tugwell
Pharmacoeconomics
|
May 31, 2002
Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada
Douglas Coyle, Andrew J Palmer, Robert Tam
Pharmacoeconomics
|
May 31, 2002
The role of models within economic analysis: focus on type 2 diabetes mellitus
Douglas Coyle, Karen M Lee, Bernie J O'Brien
Journal of Clinical Epidemiology
|
October 22, 2003
Measures of importance for economic analysis based on decision modeling
Douglas Coyle, Martin J Buxton, Bernie J O'Brien
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
International Journal of Technology Assessment in Health Care
|
September 10, 2003
Who's better not best: appropriate probabilistic uncertainty analysis
Douglas Coyle
Health Economics
|
February 4, 2003
Determining the optimal combinations of mutually exclusive interventions: a response to Hutubessy and colleagues
Douglas Coyle
Journal of Cutaneous Medicine and Surgery
|
July 1, 2005
Cost effectiveness of Elidel in the management of patients with atopic dermatitis in Canada
Douglas Coyle, Martin Barbeau
The Journal of Rheumatology. Supplement
|
January 10, 2004
Towards a reference case for economic evaluation of osteoporosis treatments
Douglas Coyle, Anna N Tosteson
The Canadian Journal of Cardiology
|
February 18, 2004
Economic evaluation of the use of irbesartan and amlodipine in the treatment of diabetic nephropathy in patients with hypertension in Canada
Douglas Coyle, Roger A Rodby
Expert Opinion on Pharmacotherapy
|
April 6, 2002
Pharmacoeconomics of long-term treatment of rheumatoid arthritis
Barbara Blumenauer, Douglas Coyle, Peter Tugwell
Pharmacoeconomics
|
June 17, 2003
Economic evaluation of norethisterone acetate/ethinylestradiol (FemHRT) for women with menopausal symptoms
Douglas Coyle, Ann Cranney, Peter Tugwell
Pharmacoeconomics
|
May 31, 2002
Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada
Douglas Coyle, Andrew J Palmer, Robert Tam
Pharmacoeconomics
|
May 31, 2002
The role of models within economic analysis: focus on type 2 diabetes mellitus
Douglas Coyle, Karen M Lee, Bernie J O'Brien
Journal of Clinical Epidemiology
|
October 22, 2003
Measures of importance for economic analysis based on decision modeling
Douglas Coyle, Martin J Buxton, Bernie J O'Brien
Page
of 5